Found: 79
Select item for more details and to access through your institution.
Anti-angiogenic therapy in glioma.
- Published in:
- Clinical & Translational Oncology, 2011, v. 13, n. 5, p. 294, doi. 10.1007/s12094-011-0657-2
- By:
- Publication type:
- Article
The Effect of Molecular Diagnostics on the Treatment of Glioma.
- Published in:
- Current Oncology Reports, 2017, v. 19, n. 4, p. 1, doi. 10.1007/s11912-017-0585-6
- By:
- Publication type:
- Article
A systematic review and meta-analysis examining the effects of cannabis and its derivatives in adults with malignant CNS tumors.
- Published in:
- Neuro-Oncology Practice, 2020, v. 7, n. 4, p. 376, doi. 10.1093/nop/npaa013
- By:
- Publication type:
- Article
Reirradiation of recurrent high-grade glioma and development of prognostic scores for progression and survival.
- Published in:
- Neuro-Oncology Practice, 2019, v. 6, n. 5, p. 364, doi. 10.1093/nop/npz017
- By:
- Publication type:
- Article
Attitudes toward fertility and fertility preservation in women with glioma.
- Published in:
- Neuro-Oncology Practice, 2019, v. 6, n. 3, p. 218, doi. 10.1093/nop/npy036
- By:
- Publication type:
- Article
Clinical trial endpoints for patients with gliomas.
- Published in:
- Neuro-Oncology Practice, 2017, v. 4, n. 4, p. 201, doi. 10.1093/nop/npw034
- By:
- Publication type:
- Article
A multicenter, phase 1, dose escalation clinical trial (G-FORCE-1) of XRT, RRx-001 and temozolomide followed by temozolomide +/- RRx-001 in newly diagnosed glioblastoma.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1176448
- By:
- Publication type:
- Article
Therapeutic advances for glioblastoma multiforme: Current status and future prospects.
- Published in:
- Current Oncology Reports, 2007, v. 9, n. 1, p. 66, doi. 10.1007/BF02951428
- By:
- Publication type:
- Article
Glioblastoma--What's Next?
- Published in:
- Oncology (08909091), 2019, v. 33, n. 3, p. 92
- By:
- Publication type:
- Article
Risk factors of radiotherapy-induced cerebral microbleeds and serial analysis of their size compared with white matter changes: A 7T MRI study in 113 adult patients with brain tumors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Functional prediction of response to therapy prior to therapeutic intervention is associated with improved survival in patients with high-grade glioma.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-68801-0
- By:
- Publication type:
- Article
Automatic Brain Tissue and Lesion Segmentation and Multi-Parametric Mapping of Contrast-Enhancing Gliomas without the Injection of Contrast Agents: A Preliminary Study.
- Published in:
- Cancers, 2024, v. 16, n. 8, p. 1524, doi. 10.3390/cancers16081524
- By:
- Publication type:
- Article
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1872, doi. 10.1093/neuonc/noab081
- By:
- Publication type:
- Article
A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE).
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 705, doi. 10.1093/neuonc/noz232
- By:
- Publication type:
- Article
Advances in multidisciplinary therapy for meningiomas.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. i18, doi. 10.1093/neuonc/noy136
- By:
- Publication type:
- Article
Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 1, p. 106, doi. 10.1093/neuonc/noy091
- By:
- Publication type:
- Article
NCOG-11. FEASIBILITY AND EFFICACY OF AN IPAD-BASED COGNITIVE REHABILITATION PROGRAM IN BRAIN TUMOR PATIENTS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi174, doi. 10.1093/neuonc/noy148.726
- By:
- Publication type:
- Article
TMIC-15. OMX IS A TUMOR MICROENVIRONMENT MODIFIER THAT RESTORES ANTI-TUMOR IMMUNITY AND IMPROVES ANTI-TUMOR EFFICACY BY REDUCING TUMOR HYPOXIA IN INTRACRANIAL GLIOBLASTOMA MOUSE MODEL.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi259, doi. 10.1093/neuonc/noy148.1074
- By:
- Publication type:
- Article
RTHP-11. REIRRADIATION OF RECURRENT HIGH GRADE GLIOMAS: OUTCOMES AND PROGNOSTIC FACTORS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi227, doi. 10.1093/neuonc/noy148.943
- By:
- Publication type:
- Article
QOLP-24. ATTITUDES TOWARD FERTILITY AND FERTILITY PRESERVATION IN WOMEN WITH GLIOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi219, doi. 10.1093/neuonc/noy148.910
- By:
- Publication type:
- Article
PATH-05. IMPLEMENTATION OF A TARGETED NEXT-GENERATION SEQUENCING PANEL FOR THE DIAGNOSIS AND PRECISION MEDICINE TREATMENT OF ADULT PATIENTS WITH WHO GRADE IV DIFFUSE GLIOMAS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi158, doi. 10.1093/neuonc/noy148.661
- By:
- Publication type:
- Article
ATIM-19. RESULTS OF THE GLOBE STUDY: A PHASE 3, RANDOMIZED, CONTROLLED, DOUBLE-ARM, OPEN-LABEL, MULTI-CENTER STUDY OF VB-111 COMBINED WITH BEVACIZUMAB VS. BEVACIZUMAB MONOTHERAPY IN PATIENTS WITH RECURRENT GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi4, doi. 10.1093/neuonc/noy148.014
- By:
- Publication type:
- Article
ATIM-05. INTRATUMORAL DELIVERY OF MDNA55, AN INTERLEUKIN-4 RECEPTOR TARGETED IMMUNOTHERAPY, BY MRI-GUIDED CONVECTIVE DELIVERY FOR THE TREATMENT OF RECURRENT GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi1, doi. 10.1093/neuonc/noy148.002
- By:
- Publication type:
- Article
CHARACTERIZATION OF RADIOTHERAPY-INDUCED CEREBRAL MICROBLEEDS WITH ULTRA-HIGH FIELD MRI: EXPERIENCE IN YOUNG AND ADULT BRAIN TUMOUR POPULATION.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. v349, doi. 10.1093/neuonc/noy129.021
- By:
- Publication type:
- Article
Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 6, p. 838, doi. 10.1093/neuonc/nox202
- By:
- Publication type:
- Article
Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 5, p. 699, doi. 10.1093/neuonc/now254
- By:
- Publication type:
- Article
Association of early changes in ¹H MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimen.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 3, p. 430, doi. 10.1093/neuonc/now159
- By:
- Publication type:
- Article
Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 242, doi. 10.1093/neuonc/now176
- By:
- Publication type:
- Article
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 4, p. 557, doi. 10.1093/neuonc/nov245
- By:
- Publication type:
- Article
The effects of anti-angiogenic therapy on the formation of radiationinduced microbleeds in normal brain tissue of patients with glioma.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 1, p. 87, doi. 10.1093/neuonc/nov128
- By:
- Publication type:
- Article
Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 9, p. 1255, doi. 10.1093/neuonc/nou044
- By:
- Publication type:
- Article
A PHASE I STUDY OF CONVECTION-ENHANCED DELIVERY OF LIPOSOMAL-IRINOTECAN USING REAL-TIME IMAGING WITH GADOLINIUM IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii13, doi. 10.1093/neuonc/nou206.46
- By:
- Publication type:
- Article
A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 7, p. 984, doi. 10.1093/neuonc/nou029
- By:
- Publication type:
- Article
Heat-shock protein peptide complex–96 vaccination for recurrent glioblastoma: a phase II, single-arm trial.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 2, p. 274, doi. 10.1093/neuonc/not203
- By:
- Publication type:
- Article
Using susceptibility-weighted imaging to determine response to combined anti-angiogenic, cytotoxic, and radiation therapy in patients with glioblastoma multiforme†.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 4, p. 480, doi. 10.1093/neuonc/nos325
- By:
- Publication type:
- Article
Comparing routes of delivery for nanoliposomal irinotecan shows superior anti-tumor activity of local administration in treating intracranial glioblastoma xenografts.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 2, p. 189, doi. 10.1093/neuonc/nos305
- By:
- Publication type:
- Article
Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 12, p. 1331, doi. 10.1093/neuonc/nor130
- By:
- Publication type:
- Article
Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 1, p. 119, doi. 10.1093/neuonc/noq143
- By:
- Publication type:
- Article
Evaluation of diffusion parameters as early biomarkers of disease progression in glioblastoma multiforme†.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 9, p. 908, doi. 10.1093/neuonc/noq049
- By:
- Publication type:
- Article
Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02).
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 8, p. 855, doi. 10.1093/neuonc/noq025
- By:
- Publication type:
- Article
Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: A phase I study†.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 6, p. 608, doi. 10.1093/neuonc/nop070
- By:
- Publication type:
- Article
Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 3, p. 274, doi. 10.1093/neuonc/nop034
- By:
- Publication type:
- Article
Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma.
- Published in:
- Neuro-Oncology, 2006, v. 8, n. 1, p. 67, doi. 10.1215/S1522851705000451
- By:
- Publication type:
- Article
GNOSIS: Guidelines for neuro-oncology: Standards for investigational studies--reporting of phase 1 and phase 2 clinical trials.
- Published in:
- Neuro-Oncology, 2005, v. 7, n. 4, p. 425, doi. 10.1215/S1152851705000554
- By:
- Publication type:
- Article
Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis).
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 1, p. 30, doi. 10.1007/s11864-022-01047-y
- By:
- Publication type:
- Article
Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Quantitative analysis of MGMT promoter methylation in glioblastoma suggests nonlinear prognostic effect.
- Published in:
- Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad115
- By:
- Publication type:
- Article
Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance).
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac041
- By:
- Publication type:
- Article
Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac025
- By:
- Publication type:
- Article